Background: Diabetic nephropathy occurs in about one-third of diabetic patients. This health problem is characterized by increased urinary albumin excretion, leading to decreased glomerular filtration rate and renal failure. In this regard, previous investigations have revealed the possibility of a relationship between vitamin D deficiency and diabetic nephropathy. The present study assessed the relationship between vitamin D deficiency and albuminuria in patients with type 2 diabetes. Methods: This study was conducted with 200 participants with type 2 diabetes mellitus from December 2019 to January 2021. The patients’ 25-hydroxyvitamin D (25OHD) serum level and urinary albumin-to-creatinine ratio (UACR) were measured concurrently. Afterward, the subjects were divided into three groups based on their albuminuria level. Finally, 25OHD serum level and other clinical characteristics were compared among these albuminuria groups, and the relation between albuminuria level and 25OHD was analyzed. Results: The prevalence of vitamin D deficiency in macroalbuminuric patients (UACR≥300 mg/g) was 61.8%, and in microalbuminuric (30 ≤ UACR< 300 mg/g) and normoalbuminuric groups (UACR< 30 mg/g) was 33.3% and 24%, respectively. Further analysis revealed a significant negative relationship between 25OHD and albuminuria(r = − 0.257, p-value< 0.001). According to ROC curve analysis, a 25OHD level ≤ 21 ng/ml was considered an optimal cut-off point value for having macroalbuminuria in diabetic patients. Conclusions: The current study evaluates the relation between vitamin D deficiency and the prevalence of albuminuria in the setting of diabetes. Overall, the prevalence of macroalbuminuria increased when the 25OHD serum level was less than 20 ng/ml.
1 April 2015 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Background: Chronic kidney disease (CKD) and end-stage renal disease (ESRD) pose significant health challenges worldwide, particularly in regions with limited access to advanced medical care. Dialysis, including hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD), remains essential in managing ESRD due to donor organ shortage. Understanding intradialytic blood pressure disorders is crucial for improving outcomes in HD patients. Methods: This cross-sectional study investigated the prevalence, predictors, and consequences of intradialytic blood pressure disorders among HD patients in Shiraz, Iran. Data were collected from 104 HD patients aged 18–75 years, with assessments including blood pressure measurements, laboratory data, dialysis settings, and other related parameters. Results: Significant blood pressure variability (BPV) during dialysis was observed in 59.6% of patients, with factors such as higher ultrafiltration amounts (p < 0.022), elevated plasma potassium levels (p < 0.018), and sleep disorders (p < 0.008) significantly associated with BPV. Intradialytic hypertension was linked to lower platelet counts (p < 0.001) and sleep disorders (p = 0.226), while intradialytic hypotension was associated with various factors including sleep medication use (p < 0.028), plasma potassium levels (p < 0.024), and gender (p = 0.021). Conclusions: Blood pressure variability during hemodialysis is common among HD patients, with factors such as ultrafiltration amounts, plasma potassium levels, and sleep disorders (as a novel factor) significantly influencing intradialytic blood pressure fluctuations. These findings underscore the complexity of managing blood pressure in HD patients and highlight the need for comprehensive assessment and tailored interventions to optimize patient care.
Cell death leads to increase serum cytokeratin 18 (CK-18) in chronic kidney disease. However, few studies have investigated the serum CK-18 level in relation to nutritional and metabolic biomarkers. We examined the association of dietary intake and lipid profile with serum CK18 level among hemodialysis (HD) patients. Ninety HD patients according to inclusion and exclusion criteria were included in the study. An analysis of clinical characteristics, anthropometric indices, dietary intake, and lipid profile revealed a significant association between serum CK-18 and diabetes, metabolic syndrome, body mass index (BMI), triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), energy intake (EI), protein intake (PI), and saturated fatty acid (SFA). In a multiple stepwise regression model, after adjusting for confounders in three models, the association between serum CK-18 and serum TG level, dietary SFA and EI remained significant. The model 3 adjusted for DM, Mets, BMI, ALT, AST, and PI; model 2 adjusted for model 1 + EI; and model 1 adjusted for model 2 + SFA. Our findings suggest that the development of hypertriglyceridemia and inadequate EI contribute to higher serum CK-18, which is a cell death biomarker.